Patent ID: 11912722
Assignee: INCYTE CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The method of claim 1, wherein:
RQ, RU, RV, and RW are each independently selected from H, halo, CN, OH, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkylamino, di(C1-6 alkyl)amino, carbamyl, C1-6 alkylcarbamyl, and di(C1-6 alkyl)carbamyl;
RQ′, RW′, RV′, and RU′ are each independently selected from H, halo, CN, OH, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkylamino, di(C1-6 alkyl)amino, carbamyl, C1-6 alkylcarbamyl, and di(C1-6 alkyl)carbamyl;
RX is selected from H, D, halo, CN, NO2, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkylamino, di(C1-6 alkyl)amino, carbamyl, C1-6 alkylcarbamyl, and di(C1-6 alkyl)carbamyl;
RX′ is selected from H, D, halo, CN, NO2, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkylamino, di(C1-6 alkyl)amino, carbamyl, C1-6 alkylcarbamyl, and di(C1-6 alkyl)carbamyl;
Ring moiety A is a pyrazole ring, which is optionally substituted with 1, 2, or 3 independently selected RA substituents;
each RA is independently selected from H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, CN, and C1-6 haloalkyl:
Ring moiety B is a pyrazole ring, which is optionally substituted with 1, 2, or 3 independently selected RB substituents;
each RB is independently selected from H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, CN, and C1-6 haloalkyl;
L1 is selected from —R—R— and —R—R—R—; and
each R is independently selected from C1-3 alkylene, C2-3 alkenylene, and C2-3 alkynylene.